Lifeward Ltd.: financial reference
Explore Lifeward Ltd. financial histories from SEC filings, with original units, reporting periods, filing dates and downloadable source data.
Limits of the selected measures
us-gaap:EarningsPerShareBasic: This EPS observation is withheld because the historical ReWalk statement labels amounts in U.S. dollars but its inline fact encodes ILS per share. The source currency conflict is retained; no conversion, relabeling or replacement value has been applied.
Inspect 3 withheld observations (period ends: 2021-12-31 to 2023-12-31)
| Period start | Period end | Original value | Unit | Source filing |
|---|---|---|---|---|
| 2021-01-01 | 2021-12-31 | -0.27 | ILS/shares | 0001178913-24-000730 |
| 2022-01-01 | 2022-12-31 | -0.31 | ILS/shares | 0001178913-24-000730 |
| 2023-01-01 | 2023-12-31 | -0.37 | ILS/shares | 0001178913-24-000730 |
us-gaap:EarningsPerShareDiluted: This EPS observation is withheld because the historical ReWalk statement labels amounts in U.S. dollars but its inline fact encodes ILS per share. The source currency conflict is retained; no conversion, relabeling or replacement value has been applied.
Inspect 3 withheld observations (period ends: 2021-12-31 to 2023-12-31)
| Period start | Period end | Original value | Unit | Source filing |
|---|---|---|---|---|
| 2021-01-01 | 2021-12-31 | -0.27 | ILS/shares | 0001178913-24-000730 |
| 2022-01-01 | 2022-12-31 | -0.31 | ILS/shares | 0001178913-24-000730 |
| 2023-01-01 | 2023-12-31 | -0.37 | ILS/shares | 0001178913-24-000730 |
Context from the filing
For ReWalk Robotics (now Lifeward), the 2023 annual filing reports 2021 basic and diluted EPS of USD -0.27 and weighted-average ordinary shares of 47,935,652. Potential ordinary shares and warrants were excluded as anti-dilutive during losses. These are historical 2021 figures from that filing, before the later 2024 and 2026 reverse splits; they are not on the same share basis as the newer filing. This review uses the USD-tagged EPS in the per-share note. The six separate ILS-tagged EPS observations remain withheld for their conflict with the statement currency; no conversion or relabeling is applied. Read the source filing.
For Lifeward’s 2023–2025 figures in its 2025 annual filing, the ordinary-share counts and per-share amounts already reflect the March 2024 one-for-seven and February 2026 one-for-twelve reverse splits. No additional adjustment is applied. Warrants, share options and convertible notes are excluded from diluted loss per share as anti-dilutive. The selected USD-per-share EPS and full scale-zero share counts are preserved. This review is limited to that filing and does not resolve the separate currency conflicts withheld from the older ReWalk filing. Read the source filing.
Reported financial histories
Choose a measure to inspect its definition, complete selected history and filing provenance. Each row shows the latest period available for that selected concept and original unit. Separate currencies and reporting intervals remain separate rows. Coverage dates can differ between concepts. A recent capture does not imply recent accounting coverage; these amounts are not prices.
| Measure | Period start | Period end | Value | Unit | Filed |
|---|---|---|---|---|---|
| Total assets | At date | 2025-12-31 | 22,900,000 | USD | 2026-03-18 |
| Total liabilities | At date | 2025-12-31 | 14,492,000 | USD | 2026-03-18 |
| Stockholders equity | At date | 2025-12-31 | 8,408,000 | USD | 2026-03-18 |
| Cash and cash equivalents | At date | 2025-12-31 | 2,169,000 | USD | 2026-03-18 |
| Net income or loss | 2025-01-01 | 2025-12-31 | -19,914,000 | USD | 2026-03-18 |
| Operating cash flow | 2025-01-01 | 2025-12-31 | -16,826,000 | USD | 2026-03-18 |
| Capital expenditure payments | 2025-01-01 | 2025-12-31 | 16,000 | USD | 2026-03-18 |
| Revenue | 2025-01-01 | 2025-12-31 | 22,034,000 | USD | 2026-03-18 |
| Contract revenue excluding tax | 2025-01-01 | 2025-12-31 | 1,400,000 | USD | 2026-03-18 |
| Financing cash flow | 2025-01-01 | 2025-12-31 | 12,203,000 | USD | 2026-03-18 |
| Investing cash flow | 2025-01-01 | 2025-12-31 | -16,000 | USD | 2026-03-18 |
| Retained earnings or deficit | At date | 2025-12-31 | -284,739,000 | USD | 2026-03-18 |
| Basic weighted-average shares | 2025-01-01 | 2025-12-31 | 1,160,521 | shares | 2026-03-18 |
| Diluted weighted-average shares | 2025-01-01 | 2025-12-31 | 1,160,521 | shares | 2026-03-18 |
| Basic earnings per share | 2025-01-01 | 2025-12-31 | -17.16 | USD/shares | 2026-03-18 |
| Diluted earnings per share | 2025-01-01 | 2025-12-31 | -17.16 | USD/shares | 2026-03-18 |
| Income tax expense or benefit | 2025-01-01 | 2025-12-31 | -55,000 | USD | 2026-03-18 |
| Net property, plant and equipment | At date | 2025-12-31 | 585,000 | USD | 2026-03-18 |
| Share-based compensation expense | 2025-01-01 | 2025-12-31 | 743,000 | USD | 2026-03-18 |
| Operating income or loss | 2025-01-01 | 2025-12-31 | -19,674,000 | USD | 2026-03-18 |
| Current assets | At date | 2025-12-31 | 15,807,000 | USD | 2026-03-18 |
| Current liabilities | At date | 2025-12-31 | 12,039,000 | USD | 2026-03-18 |
| Current accounts payable | At date | 2025-12-31 | 5,590,000 | USD | 2026-03-18 |
| Goodwill carrying amount | At date | 2025-12-31 | 4,755,000 | USD | 2026-03-18 |
| Net current accounts receivable | At date | 2025-12-31 | 6,138,000 | USD | 2026-03-18 |
| Operating expenses | 2025-01-01 | 2025-12-31 | 28,102,000 | USD | 2026-03-18 |
| Net inventory | At date | 2025-12-31 | 5,732,000 | USD | 2026-03-18 |
| Gross profit | 2025-01-01 | 2025-12-31 | 8,428,000 | USD | 2026-03-18 |
| Cost of revenue | 2025-01-01 | 2025-12-31 | 13,606,000 | USD | 2026-03-18 |
| Research and development expense | 2025-01-01 | 2025-12-31 | 3,249,000 | USD | 2026-03-18 |
Inspect the source
- Entity
- Lifeward Ltd. / CIK 0001607962
- Captured
- 2026-09-19T11:19:31.676Z
- SEC response SHA-256
65d510c294653d7f3865b561279f8eb53c45e516643e1812cfe6330a41480012
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001607962.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))